Teva, Murphy Formalize North America Headquarters Move with Ceremony in Israel - New Jersey Business Magazine
Teva 'Plagued By Problems,' Downgraded On Lost MS Drug Patents, DOJ Probe | Stock News & Stock Market Analysis - IBD
Teva Pharmaceuticals found liable in New York opioid trial - BBC News
Teva Pharmaceutical to Replace CEO Kare Schultz - WSJ
Teva stock pops on Q2 results, CEO sees 'significant' potential for trio of branded drugs
Opioid maker Teva agrees to tentative $4.25 billion deal - The Washington Post
Teva Reports Second Quarter 2023 Financial Results | Business Wire
Yahoo Finance on X: "$TEVA “has a strong future,” Teva Pharmaceuticals CEO Richard Francis says on Q2 earnings. “It's important that we keep delivering these numbers.” https://t.co/V7MDGVpXMy" / X
/arc-anglerfish-arc2-prod-pmn.s3.amazonaws.com/public/QLOB6IH57ZGW3NM55HWQDLO2BU.jpg "Teva Pharmaceutical Industries names a new CEO")
Teva Pharmaceutical Industries names a new CEO
Teva Posts 2021 Earnings and Puts Opioid Litigation in Rearview Mirror | BioSpace
Should You Sell Teva Pharmaceutical Industries Ltd (TEVA) in Drug Manufacturers - Specialty & Generic Industry?
Pharma giant Teva looks to steady ship with new CEO in coming weeks - The Times of Israel
Teva to pay $225M to settle cholesterol drug price-fixing charges | AP News
Teva shares plunge as competitors get nod for copycat flagship drug - The Times of Israel
The best Teva sandals to wear this summer
Articles about Teva Pharmaceuticals, Inc.
Jury finds Teva Pharmaceuticals fueled opioid epidemic in New York State
$300 million Teva bet: Will Norway's wealth fund and ION regret investing in the phar | Ctech
Teva Pharmaceuticals: Israeli drugmaker to cut 14,000 jobs - BBC News
Corcept Therapeutics plunges amid patent trial with Teva (NASDAQ:CORT) | Seeking Alpha
